Reimagining Precision Delivery to Enable TGF-β Therapies at Ultra-Low, Nontoxic Doses
Time: 9:30 am
day: Conference Day Two
Details:
- Proving how endothelium is the critical barrier to low dose precision therapeutic efficacy without toxicities
- New dual precision therapeutics to penetrate endothelium and to fully block TGF-β only inside the lung
- Transvascular pumping of drugs by design boosts site delivery and potency 1000x and circumnavigates toxicity
New Data!
